A long-term study with the IL-1 receptor blocker anakinra/kineret® in patients with neonatal onset multisystem inflammatory disease (NOMID/CINCA syndrome) A long-term study with the IL-1 receptor blocker anakinra/kineret® in patients with neonatal onset m ...
A long-term outcome study with the IL-1 receptor antagonist Anakinra/Kineret® in patients with Neonatal onset multisystem inflammatory disease (Nomid/Cinca syndrome) A long-term outcome study with the IL-1 receptor antagonist Anakinra/Kineret® in patients with Neona ...